1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

被引:46
|
作者
Micheli, Fabrizio [1 ]
Cavanni, Paolo [1 ]
Arban, Roberto [1 ]
Benedetti, Roberto [1 ]
Bertani, Barbara [1 ]
Bettati, Michela [1 ]
Bettelini, Letizia [1 ]
Bonanomi, Giorgio [1 ]
Braggio, Simone [1 ]
Checchia, Anna [1 ]
Davalli, Silvia [2 ]
Di Fabio, Romano [1 ]
Fazzolari, Elettra [1 ]
Fontana, Stefano [1 ]
Marchioro, Carla [2 ]
Minick, Doug [2 ,3 ]
Negri, Michele [1 ]
Oliosi, Beatrice [2 ]
Read, Kevin D. [4 ]
Sartori, Ilaria [1 ]
Tedesco, Giovanna [2 ]
Tarsi, Luca [1 ]
Terreni, Silvia [1 ]
Visentini, Filippo [2 ]
Zocchi, Alessandro [1 ]
Zonzini, Laura [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
[2] GlaxoSmithKline Med Res Ctr, Mol Discovery Res, I-37135 Verona, Italy
[3] GlaxoSmithKline Inc, Mol Discovery Res, Res Triangle Pk, NC USA
[4] Univ Dundee, Sir James Black Ctr, Coll Life Sci, Dundee DD1 5EH, Scotland
关键词
DEPRESSION; MONOAMINES; DOPAMINE;
D O I
10.1021/jm901818u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(ary1)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes are described together with detailed SA R. Appropriate decoration of the scaffolds was achieved with the help of a triple reuptake inhibitor pharmacophore model detailed here. Selected derivatives showed good oral bioavailability ( > 30%) and brain penetration (B/B > 4) in rats associated with high in vitro potency and selectivity at SERT, NET, and DAT. Among these compounds, microdialysis and in vivo experiments confirm that derivative 15 has an appropriate developability profile to be considered for further progression.
引用
收藏
页码:2534 / 2551
页数:18
相关论文
共 50 条
  • [1] ANALGETIC PROPERTIES OF 1-(SUBSTITUTEDPHENYL)-3-AZABICYCLO[3.1.0]HEXANES
    EPSTEIN, JW
    BRABANDER, HJ
    FANSHAWE, WJ
    MCKENZIE, TC
    OSTERBERG, AC
    SAFIR, SR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1978, 175 (MAR): : 17 - 17
  • [2] 6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor
    Micheli, Fabrizio
    Cavanni, Paolo
    Andreotti, Daniele
    Arban, Roberto
    Benedetti, Roberto
    Bertani, Barbara
    Bettati, Michela
    Bettelini, Letizia
    Bonanomi, Giorgio
    Braggio, Simone
    Carletti, Renzo
    Checchia, Anna
    Corsi, Mauro
    Fazzolari, Elettra
    Fontana, Stefano
    Marchioro, Carla
    Merlo-Pich, Emilio
    Negri, Michele
    Oliosi, Beatrice
    Ratti, Emiliangelo
    Read, Kevin D.
    Roscic, Maja
    Sartori, Ilaria
    Spada, Simone
    Tedesco, Giovanna
    Tarsi, Luca
    Terreni, Silvia
    Visentini, Filippo
    Zocchi, Alessandro
    Zonzini, Laura
    Di Fabio, Romano
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (13) : 4989 - 5001
  • [3] 1-ARYL-3-AZABICYCLO[3.1.0]HEXANES, A NEW SERIES OF NON-NARCOTIC ANALGESIC AGENTS
    EPSTEIN, JW
    BRABANDER, HJ
    FANSHAWE, WJ
    HOFMANN, CM
    MCKENZIE, TC
    SAFIR, SR
    OSTERBERG, AC
    COSULICH, DB
    LOVELL, FM
    JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (05) : 481 - 490
  • [4] Synthesis of trovafloxacin using various (1α,5α,6α)-3-azabicyclo[3.1.0]hexane derivatives
    Norris, T
    Braish, TF
    Butters, M
    DeVries, KM
    Hawkins, JM
    Massett, SS
    Rose, PR
    Santafianos, D
    Sklavounos, C
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 2000, (10): : 1615 - 1622
  • [5] Synthesis of trovafloxacin using various (1α,5α,6α)-3-azabicyclo[3.1.0]hexane derivatives
    Pfizer Central Research Laboratories, Groton, CT 06340, United States
    Journal of the Chemical Society, Perkin Transactions 1, 2000, (10): : 1615 - 1622
  • [6] Site-Selective C(sp3)-H Borylation of 3-Azabicyclo[3.1.0]hexanes by Cooperative Iridium/Aluminum Catalysis
    Shimazaki, Yuto
    Osawa, Ayumi
    Nakao, Yoshiaki
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2024, 13 (02)
  • [7] Antiproliferative Activity Missing in 6-Substituted Polycarbonitrile Derivatives of 3-Azabicyclo[3.1.0]Hexane
    I. N. Bardasov
    A. Yu. Alekseeva
    O. V. Ershov
    M. A. Mar’yasov
    Pharmaceutical Chemistry Journal, 2020, 54 : 781 - 783
  • [8] Antiproliferative Activity Missing in 6-Substituted Polycarbonitrile Derivatives of 3-Azabicyclo[3.1.0]Hexane
    Bardasov, I. N.
    Alekseeva, A. Yu
    Ershov, O., V
    Mar'yasov, M. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2020, 54 (08) : 781 - 783
  • [9] Hydrolysis of 6-Aryl-2-amino-4-(dicyanomethylidene)-3-azabicyclo[3.1.0]hex-2-ene-1,5-dicarbonitriles
    I. N. Bardasov
    A. U. Alekseeva
    O. V. Ershov
    Russian Journal of Organic Chemistry, 2019, 55 : 1077 - 1080
  • [10] Hydrolysis of 6-Aryl-2-amino-4-(dicyanomethylidene)-3-azabicyclo[3.1.0]hex-2-ene-1,5-dicarbonitriles
    Bardasov, I. N.
    Alekseeva, A. U.
    Ershov, O., V
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2019, 55 (08) : 1077 - 1080